GIORGI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 1849
EU - Europa 493
AS - Asia 149
SA - Sud America 20
AF - Africa 4
OC - Oceania 1
Totale 2516
Nazione #
US - Stati Uniti d'America 1836
IT - Italia 307
IN - India 91
CN - Cina 57
SE - Svezia 50
FI - Finlandia 41
UA - Ucraina 37
CA - Canada 13
DE - Germania 13
BR - Brasile 11
GB - Regno Unito 11
BG - Bulgaria 9
AR - Argentina 8
BE - Belgio 6
RO - Romania 6
IE - Irlanda 4
CZ - Repubblica Ceca 3
FR - Francia 3
TG - Togo 3
CL - Cile 1
ES - Italia 1
IR - Iran 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 2516
Città #
Fairfield 378
Woodbridge 185
Seattle 131
Dearborn 129
Ashburn 127
Houston 119
Rome 114
Wilmington 102
Cambridge 99
Ann Arbor 71
Chandler 66
Princeton 58
San Paolo di Civitate 51
Plano 46
Lawrence 36
Boston 33
Millbury 26
Beijing 25
San Diego 22
Fremont 19
Norwalk 18
Andover 12
Jacksonville 12
Sofia 9
Toronto 9
Falls Church 8
Federal 8
Boardman 7
Brussels 6
Nanjing 6
Anzio 4
Dublin 4
Fasano 4
Ottawa 4
Redwood City 4
Buffalo 3
Guangzhou 3
Hefei 3
Indiana 3
Jinan 3
Kunming 3
Lomé 3
Phoenix 3
Bremen 2
London 2
Riva 2
Shenyang 2
Verona 2
Auckland 1
Baotou 1
Chengdu 1
Chicago 1
Chongqing 1
Des Moines 1
Fuzhou 1
Grugliasco 1
Hangzhou 1
Harbin 1
Hebei 1
Henderson 1
Kish 1
L'aquila 1
La Canada Flintridge 1
Las Vegas 1
Laurel 1
Manchester 1
Modena 1
Muizenberg 1
Nanchang 1
North Shields 1
Oslo 1
Padova 1
Rocca Di Papa 1
Sant Vicenç dels Horts 1
Wenzhou 1
Wuhan 1
Yellow Springs 1
Totale 2015
Nome #
Identification of murine phosphodiesterase 5A isoforms and their functional characterization in HL-1 cardiac cell line 114
Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions 98
Egr1 maintains NSC proliferation and its overexpression counteracts cell cycle exit triggered by the withdrawal of Epidermal Growth Factor 82
Metabolic role of cGMP in S. cerevisiae: the murine phosphodiesterase-5 activity affects yeast cell proliferation by altering the cAMP/cGMP equilibrium 79
Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain 76
The oligomeric assembly of the phosphodiesterase-5 is a mixture of dimers and tetramers: a putative role in the regulation of function 76
Immunohistochemical localisation of PDE5 in Leydig and myoid cells of prepuberal and adult rat testis 75
Phosphodiesterase-10A inverse changes in striatopallidal and striatoentopeduncular pathways of a transgenic mouse model of DYT1 dystonia 75
Expression of PDE5 splice variants during ontogenesis of chick dorsal root ganglia 73
Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival 67
cAMP-dependent induction of PDE5 expression in murine neuroblastoma cell differentiation 67
Gene expression and protein localization of calmodulin-dependent phosphodiesterase during ontogenesis of chick retina 64
Fluorometric detection of protein-ligand engagement: The case of phosphodiesterase5 63
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 62
Differential expression and localization of calmodulin-dependent phosphodiesterase genes during ontogenesis of chick dorsal root ganglion 60
Zaprinast impairs spatial memory by increasing PDE5 expression in the rat hippocampus 59
Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa 59
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism? 58
Use of the KlADH3 promoter for the quantitative production of the murine PDE5A isoforms in the yeast Kluyveromyces lactis 58
A preparative method for isolation of peroxisomes from rat kidney. 57
Spectrin oligomerization is cooperatively coupled to membrane assembly: A linkage targeted by many hereditary hemolytic anemias? 56
The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task 55
RANTES and human sperm fertilizing ability: Effect on acrosome reaction and sperm/oocyte fusion 55
Type 5 phosphodiesterase expression in the human vagina 55
Gene expression and protein localization of calmodulin-dependent phosphodiesterase in adult rat retina 52
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 52
Immunohistochemical localisation of PDE5 in rat lung during pre-and postnatal development. 52
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: New aspects in the pathogenetic mechanisms 52
Regulation of phosphodiesterase 5 expression and activity in human pregnant and non-pregnant myometrial cells by human chorionic gonadotropin 50
Subcellular localization and regulation of type-1C and type-5 phosphodiesterases 47
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 42
null 41
Targeting cyclic AMP signalling in hepatocellular carcinoma 37
null 37
A2a receptor dysregulation in dystonia dyt1 knock-out mice 37
null 35
Aflatoxin B1 is an inhibitor of cyclic nucleotide phosphodiesterase activity 34
Opposite changes of Phosphodiesterase-10A in striato-pallidal and striato-entopeduncular pathways of TorsinA DYT1 transgenic mice 34
Phosphodiesterases expression during murine cardiac development 31
null 30
Different mouse genetic models of human DYT1 dystonia share changes of phosphodiesterase-10A in basal ganglia circuits. 29
In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors 28
null 26
null 24
Phosphodiesterase specific inhibitors control cell growth of a human neuroepithelioma cell line 23
Wild-Type and Mutant FUS Expression Reduce Proliferation and Neuronal Differentiation Properties of Neural Stem Progenitor Cells 22
Phosphodiesterase 10A and cyclic nucleotide catabolism in the physiopathology of experimental parkinsonism 21
Torsin-a DYT1-transgenic mice overexpress phosphodiesterase 10A in striato-nigral and striato-pallidal pathways. 21
Phosphodiesterase-10A changes in basal ganglia circuits in two mouse genetic models of DYT1 Dystonia. 21
Hyper-expression of phosphodiesterase-10A in striato-nigral and striato-pallidal pathways of Torsin-A knock-in mice 19
Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms 14
Investigation on phosphodiesterase 10A control over D1-mediated facilitation of GABA release in the striato-nigral projections under normal and dopamine-depleted condictions in murine midbrain slices. 14
Levodopa induced alterations in cyclic nucleotide levels, a new aspect in the pathogenetic mechanism of Parkinson's disease 14
Phosphodiesterase 4d depletion/inhibition exerts anti-oncogenic properties in hepatocellular carcinoma 13
Phosphodiesterase 5a signalling in skeletal muscle pathophysiology 11
Dystonia: sparse synapses for D2 receptors in striatum of a DYT1 knock-out mouse model 7
Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of autism spectrum disorder 7
PDE10A is up-regulated in Enkephalin striatal projection neurons of a transgenic mouse model of DYT1 Dystonia 1
Levodopa-induced dyskinesia is associated with change in striatal cyclic nucleotides levels and cGMP hydrolyzing phosphodiesterase activity 1
Totale 2622
Categoria #
all - tutte 4093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4093


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201811 0000 00 00 0074
2018/2019388 32204 132 413 764142114
2019/2020816 10423530 70158 120125 91393120
2020/2021277 31251517 230 510 36661822
2021/2022553 5436717 6812 1861 354067120
2022/2023380 1101041831 3413 1219 39000
Totale 2622